rs3088241

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031307.4(PUS3):​c.1380G>C​(p.Glu460Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.498 in 1,613,484 control chromosomes in the GnomAD database, including 201,370 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 16801 hom., cov: 31)
Exomes 𝑓: 0.50 ( 184569 hom. )

Consequence

PUS3
NM_031307.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.00800

Publications

28 publications found
Variant links:
Genes affected
PUS3 (HGNC:25461): (pseudouridine synthase 3) The protein encoded by this gene catalyzes the formation of tRNA pseudouridine from tRNA uridine at position 39 in the anticodon stem and loop of transfer RNAs. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
HYLS1 (HGNC:26558): (HYLS1 centriolar and ciliogenesis associated) This gene encodes a protein localized to the cytoplasm. Mutations in this gene are associated with hydrolethalus syndrome. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Oct 2008]
HYLS1 Gene-Disease associations (from GenCC):
  • hydrolethalus syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • hydrolethalus syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.976661E-5).
BP6
Variant 11-125893851-C-G is Benign according to our data. Variant chr11-125893851-C-G is described in ClinVar as [Benign]. Clinvar id is 1168501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.514 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PUS3NM_031307.4 linkc.1380G>C p.Glu460Asp missense_variant Exon 4 of 4 ENST00000227474.8 NP_112597.4 Q9BZE2
HYLS1NM_001134793.2 linkc.-26+2379C>G intron_variant Intron 2 of 2 ENST00000425380.7 NP_001128265.1 Q96M11A0A024R3K0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PUS3ENST00000227474.8 linkc.1380G>C p.Glu460Asp missense_variant Exon 4 of 4 1 NM_031307.4 ENSP00000227474.3 Q9BZE2
HYLS1ENST00000425380.7 linkc.-26+2379C>G intron_variant Intron 2 of 2 3 NM_001134793.2 ENSP00000414884.2 Q96M11

Frequencies

GnomAD3 genomes
AF:
0.469
AC:
71155
AN:
151736
Hom.:
16794
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.401
Gnomad AMI
AF:
0.417
Gnomad AMR
AF:
0.454
Gnomad ASJ
AF:
0.524
Gnomad EAS
AF:
0.531
Gnomad SAS
AF:
0.497
Gnomad FIN
AF:
0.509
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.499
Gnomad OTH
AF:
0.436
GnomAD2 exomes
AF:
0.492
AC:
123742
AN:
251382
AF XY:
0.496
show subpopulations
Gnomad AFR exome
AF:
0.400
Gnomad AMR exome
AF:
0.457
Gnomad ASJ exome
AF:
0.517
Gnomad EAS exome
AF:
0.536
Gnomad FIN exome
AF:
0.511
Gnomad NFE exome
AF:
0.497
Gnomad OTH exome
AF:
0.491
GnomAD4 exome
AF:
0.502
AC:
733023
AN:
1461630
Hom.:
184569
Cov.:
39
AF XY:
0.502
AC XY:
365269
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.395
AC:
13217
AN:
33472
American (AMR)
AF:
0.456
AC:
20384
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.521
AC:
13604
AN:
26130
East Asian (EAS)
AF:
0.541
AC:
21461
AN:
39696
South Asian (SAS)
AF:
0.518
AC:
44661
AN:
86254
European-Finnish (FIN)
AF:
0.512
AC:
27339
AN:
53418
Middle Eastern (MID)
AF:
0.429
AC:
2475
AN:
5766
European-Non Finnish (NFE)
AF:
0.504
AC:
560128
AN:
1111780
Other (OTH)
AF:
0.493
AC:
29754
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
21273
42547
63820
85094
106367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16354
32708
49062
65416
81770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.469
AC:
71191
AN:
151854
Hom.:
16801
Cov.:
31
AF XY:
0.470
AC XY:
34862
AN XY:
74174
show subpopulations
African (AFR)
AF:
0.401
AC:
16596
AN:
41398
American (AMR)
AF:
0.454
AC:
6938
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.524
AC:
1815
AN:
3464
East Asian (EAS)
AF:
0.531
AC:
2740
AN:
5160
South Asian (SAS)
AF:
0.497
AC:
2384
AN:
4796
European-Finnish (FIN)
AF:
0.509
AC:
5351
AN:
10514
Middle Eastern (MID)
AF:
0.442
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
0.499
AC:
33927
AN:
67934
Other (OTH)
AF:
0.441
AC:
930
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1888
3777
5665
7554
9442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.492
Hom.:
13827
Bravo
AF:
0.462
TwinsUK
AF:
0.492
AC:
1826
ALSPAC
AF:
0.517
AC:
1992
ESP6500AA
AF:
0.404
AC:
1779
ESP6500EA
AF:
0.499
AC:
4289
ExAC
AF:
0.493
AC:
59852
Asia WGS
AF:
0.503
AC:
1752
AN:
3478
EpiCase
AF:
0.484
EpiControl
AF:
0.480

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
11
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0085
T;T;.
Eigen
Benign
-0.91
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.60
.;T;T
MetaRNN
Benign
0.00010
T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Uncertain
2.4
M;M;.
PhyloP100
-0.0080
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.14
N;N;.
REVEL
Benign
0.041
Sift
Benign
0.15
T;T;.
Sift4G
Benign
0.19
T;T;T
Polyphen
0.0030
B;B;.
Vest4
0.032
MutPred
0.092
Loss of helix (P = 0.0196);Loss of helix (P = 0.0196);.;
MPC
0.084
ClinPred
0.0072
T
GERP RS
-2.1
Varity_R
0.036
gMVP
0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3088241; hg19: chr11-125763746; COSMIC: COSV57104607; COSMIC: COSV57104607; API